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Abstract
A polylysine partially substituted with polyhydroxyalkanoyl residues and specially with gluconoyl residues was
developed in order to increase the transfection efficiency by decreasing the strength of the electrostatic interactions between
the DNA and the cationic polymer. Partially gluconoylated polylysinerDNA complexes were more easily dissociated in
solution and their transfection efficiency in the presence of chloroquine, evaluated with HepG2 cells, a human hepatocarci-
noma line, was higher when 43"4% of the e-amino groups of polylysine were blocked with gluconoyl residues. Partially
gluconoylated polylysinerplasmid complexes were efficient in transfecting different adherent as well as non-adherent cell
 .lines. Partially gluconoylated polylysine formed highly soluble above 100 mgrml in DNA complexes with DNA
plasmids. In addition, partially gluconoylated polylysine bearing few lactosyl residues increased the transfection efficiency
of HepG2 cells which express a galactose-specific membrane lectin.
Keywords: Gene therapy; Gene transfer; Polylysine; Chloroquine
1. Introduction
Polylysine conjugated to either proteins, peptides,
carbohydrates or metabolites as recognition signals
are suitable non-viral vectors when complexed with
DNA plasmids to selectively deliver genes into eu-
 w x.karyotic cells for reviews, see Refs. 1–3 . The
DNA in such complexes is highly condensed with
w xpolylysine conjugates 4–6 due to strong electro-
static interactions between the negative charges of the
Abbreviations: DP, degree of polymerization; FBS, fetal
bovine serum; GlcA, gluconoyl residue; Lact, lactosyl residue;
PBS, phosphate-buffered saline, pH 7.4; pLK, poly-L-lysine.
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DNA and the positive charges of the polylysine
w xconjugates. As previously shown 7 , the strength of
the electrostatic interactions between DNA and lacto-
sylated polylysine appears to be a limiting factor for
a highly efficient gene delivery: the dissociation of
the plasmid from lactosylated polylysine and the
transfection efficiency of HepG2 cells by lactosylated
polylysinerplasmid complexes were higher when
 .one-third of the amino groups of polylysine DP 190
were substituted with lactosyl residues than with an
unsubstituted polylysine or a polylysine substituted
with less than one-fourth of lactosyl residues. Thus,
the decrease in the strength of the electrostatic inter-
actions between a plasmid and polylysine could im-
prove the transfection efficiency of DNArpolylysine
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complexes by increasing the dissociation of the com-
plexes inside the cells in order to allow genes to
become available to the nucleus machinery.
In this report, we describe the preparation of a
polylysine partially acylated upon treatment with d-
gluconolactone in order to decrease its number of
positive charges. We show that a plasmid complexed
with a polylysine having 43"4% of its e-amino
groups blocked with gluconoyl residues was more
easily dissociated in solution and was much more
efficient to transfect various cell lines than a plasmid
complexed with an unsubstituted polylysine. More-
over, partially gluconoylated polylysine may be addi-
tionally substituted with a limited number of small
recognition signals such as carbohydrates in order to
transfect cells expressing membrane lectins, in a
sugar-dependent manner.
2. Materials and methods
2.1. Preparation of gluconoylated polylysines
( )GlcApLK
Poly-L-lysine, HBr pLK, average Mrs40 000;
. average degree of polymerization DPs190 Bachem
. Feinchemikalien, Bubendorf, Switzerland 1 g in
.200 ml H O was passed through an anion exchange2
 y .column Dowex 2=8, OH form, 20–50 mesh in
w xorder to remove bromide ions 8 which are highly
w xcytotoxic 9 . The eluate was neutralized with a 10%
p-toluene sulfonic acid solution in water and
freezed-dried. Poly-L-lysine was partially substituted
 . w xwith gluconoyl residues GlcA as described 8 ;
 .briefly, d-gluconolactone 11–35 mg; 61–194 mmol
 .Aldrich, Strasbourg, France was added to polyly-
 .sine p-toluene sulfonate salt 50 mg; 0.86 mmol in 3
 .ml dimethylsulfoxide Aldrich in the presence of
 .diisopropylethylamine 12–37 ml; 68–205 mmol
 .Aldrich and 1% H O and the solution was stirred2
for 24 h at 208C. GlcApLK was precipitated by
adding 10 volumes of isopropanol and spun down by
 .centrifugation 1800=g for 15 min . The pellet was
washed with isopropanol, collected by centrifugation
 .1800=g for 15 min , solubilized in distilled water
and freezed-dried. The average number of GlcA
 .molecules bound per pLK molecule x was deter-
mined by 1H-NMR spectroscopy at 300 MHz in D O2
Fig. 1. Structure of partially gluconoylated polylysine.
 .according to: xs3r2. h rh . DP, where hGlcA Lys GlcA
was the value of the integration of the signal in the
range from 3.6 to 3.9 ppm corresponding to the 4
 . protons 1H C , 1H C and 2H C of GlcA Fig.10 11 12
.1 , h that in the range from 1.3 to 1.9 ppmLys
corresponding to the 6 methylene protons C , C3 4
.  .and C of lysine residues Fig. 1 and where DP was5
the degree of polymerization of pLK.
2.2. Preparation of lactosylated and gluconoylated
( )polylysine Lact-, GlcApLK
Polylysine bearing an average number of 30 lacto-
syl residues per pLK molecule Lact pLK, 50 mg;30
. w x0.75 mmol prepared as described 7,10 dissolved in
3 ml of dimethylsulfoxide was stirred with d-gluco-
nolactone ranging from 1.3 to 6.6 mg 7.5–37.5
. mmol in the presence of diisopropylethylamine 22
.ml; 150 mmol and 1% H O for 24 h at 208C. Lact-,2
GlcApLK was purified by precipitation as described
above.
2.3. Cell culture
HepG2 human hepatoma cells, ATCC HB 8065,
. ATCC, Rockville, MA and Rb-1 rabbit smooth
muscle cells, M. Nachtigal, University of South Car-
. w xolina, Columbia, SC 11 cells were cultured in
 .DMEM Gibco, Renfrewshire, UK supplemented
with 10% heat-inactivated fetal bovine serum FBS,
.  .Gibco ; HeLa cells ATCC CCL 2.1 in DMEM with
5% FBS; B16 cells murine melanoma cells, D.
.Klatzman, La Pitie Salepetriere, Paris, France in´ `
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DMEM with 10% heat-inactivated newborn calf
 . serum Gibco ; HOS cells human osteosarcoma cells,
.  .ATCC CRL 1543 in MEM Gibco with 10% FBS;
3LL cells Lewis lung carcinoma cells, F. Lavelle,
.Rhone-Poulenc Rorer, Paris, France in MEM withˆ
Hanks’ salts and 20% FBS; HEL human ery-
throleukaemia cells, F. Smajda-Joffe, INSERM U268,
. Villejuif, France , K562 human erythroleukaemia
. cells, ATCC CCL 243 , HL60 human promyelocytic
cells, E. Le Floch, Rhone-Poulenc Rorer, Paris,ˆ
. France and Jurkat human T-cell leukaemia cells,
.  .ATCC TIB 152 cells in RPMI 1640 Gibco with
10% FBS; THP1 cells human myelocytic cells, J.
.Balzarini, Leuven, Belgium in RPMI 1640 with 10%
FBS in the presence of 5=10y5 M 2-mercapto-
ethanol; RBE4 cells rat brain endothelial cells, P.O.
.Couraud, Institut Cochin, Paris, France in collagen-
coated culture plates in a-MEMrHam’s F10 1r1;
.  .  .v:v Gibco with 10% FBS, bFGF 1 ngrml and
 .geneticin G418 Gibco . All culture media were sup-
plemented with 2 mM L-glutamine Merck, Darm-
. stadt, Germany and antibiotics 100 unitsrml peni-
.cillin and 100 mgrml streptomycin, Eurobio, France .
Cells were mycoplasma-free as evidenced by the
 . w xbisbenzimidazole Hoechst 33258 12 and the
w xBVC-kanamycin A staining methods 13 .
2.4. Plasmids
 . w x  .pSV2 LUC 5 kb 14 and pCMVLUC 6.2 kb
 .J.P. De Villartay, Hopital Necker, Paris, Franceˆ
were expression plasmids encoding the firefly lu-
ciferase gene under the control of the SV40 large T
antigen and the human cytomegalovirus promoters,
respectively. LPS content measured with the
BioWhittaker QCL-1000 chromogenic Limulus as-
. w xsay, BioWhittaker, Verviers, Belgium 15 was 0.08
and 2 EUrmg DNA for pSV2 LUC and pCMVLUC
plasmids, respectively and 0.02 EUrmg for poly-
mers. With this assay, 10 pgrml LPS from Es-
.cherichia coli 0.55: B5; BioWittaker batch 3L0120
gave 0.1 EUrml.
2.5. Formation of polymerrplasmid complexes
Complexes were prepared by adding, dropwise and
with constant mixing, various amounts of either pLK,
GlcApLK, LactpLK or Lact-, GlcApLK in 0.3 ml
 .serum-free DMEM to 5 mg 1.5 pmol plasmid in 0.7
ml of serum-free DMEM. The mixed solution was
kept for 30 min at 208C before use. Complexes made
with the lowest polymer to DNA molar ratio leading
to a complete retardation of all the DNA in 0.6%
agarose gel electrophoresis were used for transfection
w x7 .
2.6. Gene transfer with polymerrplasmid complexes
 5 .Adherent cell lines 2–4=10 cells were plated
 . 2 day 0 into 4 cm culture dishes 12-well culture
.plates . On day 1, the medium was removed and 1 ml
of a solution containing a polymerrplasmid complex
supplemented with 1% FBS and made 100 mM in
 .chloroquine Sigma , was added into each well.
Non-adherent cell lines in exponential growth phase,
 .were collected by centrifugation 600=g for 5 min
 6 .and suspended 1=10 cells in 1 ml of a solution
containing a polymerrplasmid complex supple-
mented with 1% FBS and made 100 mM in chloro-
quine. After 4 h incubation at 378C in a humidified
 .atmosphere 95% air, 5% CO , the medium was2
removed and cells were further incubated at 378C in
2 ml of the relevant complete culture medium in a
 .humidified atmosphere 95% air, 5% CO . HepG22
cells were also transfected in the presence 10 mM of
the fusogenic peptide E5CA: GLFEAIAEFIEGG-
. w xWEGLIEGCA 10 instead of 100 mM chloroquine.
2.7. Transfection with DEAE-dextran
Transfections were performed as described by
w x  5.Rupprecht and Coleman 16 . HepG2 cells 4=10
were plated on day 0 into 4 cm2 culture dishes; the
medium was removed on day 1 and cells were incu-
bated for 4 h at 378C in a humidified atmosphere
 .95% air, 5% CO , in 1 ml of DMEM containing2
2% FBS, 250 mgrml of DEAE-dextran 50 mgrml
.stock solution sterilized through a 0.22-mm filter
 .and 5 mg 1.5 pmol pSV2 LUC. Then the medium
was removed, cells were washed twice with DMEM
and further incubated for 48 h at 378C in 2 ml of
fresh complete DMEM supplemented with 10% FBS
in the absence of any other additive in a humidified
 .atmosphere 95% air, 5% CO .2
2.8. Lipofection
pSV2 LUC was complexed with lipofectin reagent
w x17,18 according to the manufacturer’s recipe.
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 .pSV2 LUC 10 mg in 50 ml H O and lipofectin2
reagent 10, 20 and 30 mg in 50 ml H O; DNA to2
.lipofectin weight ratio 1:1, 1:2 and 1:3, respectively
were gently mixed in a polystyrene tube and incu-
bated at 208C for 15 min. The lipofectinrpSV2 LUC
 .complexes 0.1 ml were then added to 2 ml of
 5.serum-free DMEM. HepG2 cells 4=10 were
plated on day 0 into 4-cm2 culture dishes; the medium
was removed on day 1 and cells were incubated for 4
h at 378C in a humidified atmosphere 95% air, 5%
.CO , with 1 ml of lipofectinrpSV2 LUC complexes2
 .1.5 pmol DNA in serum-free DMEM. The medium
was then removed and cells were incubated for 48 h
at 378C in 2 ml fresh complete DMEM supplemented
with 10% FBS in the absence of any other additive in
 .a humidified atmosphere 95% air, 5% CO .2
2.9. Luciferase and protein assays
Gene expression was measured by assaying the
w xluciferase-induced luminescence 19 as previously
w xdescribed 7,10 . The luminescence was recorded for
4 s with a luminometer Lumat LB 9501, Berthold,
.Wildbach, Germany ; RLUrmg protein expressed
the light emitted by one mg protein. RLU of 5 pgrml
luciferase was 10 000. Data shown are the mean
values from three independent experiments. Protein
content was determined for each sample by using the
 .bicinchoninic acid BCA, Sigma colorimetric method
w x w x w x20 modified according to Ref. 21 as described 7 .
2.10. Analysis of the strength of the polymerrDNA
interaction
 .pSV2 LUC 5 mg; 1.5 pmol in 0.7 ml of PBS was
complexed by adding, dropwise with constant mix-
 . ing, either pLK 2.5 mg; 43 pmol , GlcA pLK 7.574
.  .mg; 108 pmol or GlcA pLK 10 mg; 170 pmol in110
0.3 ml of PBS. The solution was kept for 30 min at
208C. The effect of the ionic strength on the stability
of the complexes was studied by increasing the con-
centration of NaCl upon adding aliquots of a 4-M
stock solution. After 15 min at 208C, solutions were
 .passed through nitrocellulose filters 0.45 mm , pre-
soaked and rinsed with a solution containing the
same concentration of salt. The amount of free DNA
was determined from the fluorescence intensities
 .l s360 nm; l s450 nm of the filtrates madeexc em
2.8 mM in 4X,6-diamidino-2-phenylindole, dihydro-
 . w xchloride DAPI 22 . The percentage of
polycationrDNA complex was calculated according
w .  .xto: I -I r I -I =100, where ‘I ’ was the fluores-T T 0 T
cence intensity of DAPI in the presence of the total
amount of DNA, ‘I’ that of DAPI in the filtrate
containing free DNA and ‘I ’ that of DAPI in the0
absence of DNA in solution containing the same
concentration of salt as in the sample, in order to take
into account the effect of salt on the fluorescence
intensity of DAPI in the absence of DNA.
3. Results
3.1. GlcApLKrplasmid complexes
 .pLK DP 190 was partially substituted with GlcA
 .Fig. 1 , in order to decrease the number of positive
charges born by the polypeptide and consequently to
lower the strength of the electrostatic interactions
between the polycation and a plasmid DNA. GlcA
residue is a polyhydroxyalkanoyl moiety which does
not contain any charge but five hydroxyl groups, does
not contain any aldehyde or ketone group but a
carboxyl group and therefore has no relation with a
carbohydrate molecule. In addition, there are no GlcA
receptors known on the surface of cells so far.
pSV2 LUC was complexed with various amounts
of GlcApLK containing up to 130 GlcA. The com-
plexes were made with the lowest polymer to DNA
molar ratio leading to a complete retardation of all
the DNA in electrophoresis through a 0.6% agarose
w xgel. As previously described 7 , under these condi-
tions more than 95% of GlcApLK was complexed
with the plasmid and this clear solution was used to
transfect cells without any further purification.
3.2. Analysis of the strength of the GlcApLKrplasmid
interaction
The strength of the interaction between pSV2 LUC
and GlcApLK was investigated in an acellular system
w xin the presence of salts as previously described 7
 .Fig. 2 . Free DNA passed through a nitrocellulose
 .filter 0.45 mm in diameter while DNA complexed
with GlcApLK as well as GlcApLK were retained on
the filter. The dissociation between DNA and
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Fig. 2. Analysis of the strength of the polymerrDNA interaction.
 .  . pSV2 LUC 1.5 pmol was complexed with either B pLK 2.5
.  .  .  .mg; 43 pmol , ‘ GlcA pLK 6 mg; 108 pmol or v74
 .GlcA pLK 10 mg; 170 pmol in 1 ml of PBS for 30 min at110
208C. Then, the NaCl concentration was increased up to 2 M by
addition of aliquots of a 4 M NaCl solution in PBS. After 15 min
at 208C, each solution was passed through a nitrocellulose filter
and the amount of free DNA in filtrates was determined upon
adding DAPI by measuring the fluorescence intensity with a
 .spectrofluorometer l s360 nm; l s450 nm . The percent-exc em
age of GlcApLKrDNA complex was calculated as described in
Section 2.
GlcApLK depended on the number of GlcA molecules
bound per pLK molecule. The NaCl concentration
required to dissociate 50% of the complex was 1.5
M, 1.0 M and 0.6 M when pLK was substituted with
0, 74 and 110 GlcA, respectively, showing that the
strength of the complexes decreased when the num-
 .ber of positive charges of pLK decreased Fig. 2 .
3.3. Gene transfer into HepG2 cells with GlcApLKr
plasmid complexes
The transfection of H epG 2 cells by
GlcApLKrpSV2 LUC complexes in the presence of
chloroquine was quite efficient and with a maximum
when 43"4% of the amino groups of pLK 82"8
.GlcA in the case of a pLK with a DPs190 were
 .substituted with GlcA Fig. 3A . The luciferase activ-
ity was very low when cells were incubated in the
presence of chloroquine by using complexes made
with pLK substituted with a small number of GlcA
 . 40 or less or with a large number of GlcA 100 or
.  .more Fig. 3A . The transfection efficiency by
GlcA pLKrpSV2 LUC complexes depended on the74
 .GlcApLKrDNA molar ratio Fig. 3B . It was more
efficient when this molar ratio was between 70 and
170 than below 70 or above 170. These results were
expected on the basis of the ratio required to make
complexes leading to a complete retardation of all the
plasmid in electrophoresis. Indeed, when complexes
 .were made with a GlcApLKrDNA molar ratio: 1
lower than 70, all the plasmid was not completely
retarded, the medium contained GlcApLK-free DNA
 .molecules and the transfection was not efficient; 2
between 70 and 170, all the plasmid was completely
retarded and the medium contained less than 5%
Fig. 3. Gene transfer into HepG2 cells with GlcApLKrpSV2 LUC
 .complexes. A Influence of the number of GlcA molecules
 .bound per pLK molecule GlcArpLK . Complexes were formed
 .between pSV2 LUC 1.5 pmol in 0.7 ml of DMEM and pLK
bearing either 0, 17, 31, 40, 50, 59, 74, 90, 105 or 127 GlcA in
 5.0.3 ml of DMEM. HepG2 cells 4=10 were transfected at
378C for 4 h in 1 ml of DMEM containing a complex, 1% FBS
 .and 100 mM chloroquine. B Influence of the polymer to
 .  5.plasmid molar ratio GlcApLKrDNA . HepG2 cells 4=10
were transfected at 378C for 4 h in 1 ml of DMEM containing
 .1% FBS, 100 mM chloroquine and pSV2 LUC 1.5 pmol com-
plexed with various amounts of GlcA pLK. Gene expression in74
 .  .A and B was determined 48 h later by assaying the luciferase
activity in cell lysates.
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 .DNA-free GlcApLK molecule; and 3 above 170, all
the plasmid was completely retarded but the medium
contained DNA-free GlcApLK for instance, 30% at
.a ratio of 300 which may interact with the cell
s u r f a c e , im p a i r in g th e u p ta k e o f
GlcApLKrpSV2 LUC complexes and inducing toxic-
ity for instance, with 0.25 mM GlcA pLK, a con-74
centration present in a complex made with a
GlcApLKrDNA molar ratio of 300, 10% of HepG2
.cells were killed . Upon transfection in the absence of
chloroquine, the luciferase activity was very low
 3.RLUrmg-10 . Alternatively, the luciferase-in-
duced luminescence of HepG2 cells transfected with
a GlcA pLKrplasmid complex in the presence of74
w x10 mM E5CA fusogenic peptide 10 was as high as
that obtained in the presence of 100 mM chloroquine
 .data not shown . The transfection efficiency of
HepG2 cells with GlcA pLKrpSV2 LUC com-74
plexes was compared with that obtained with two
other non-viral methods. The transfection with
 .DEAE-dextran even after a glycerol shock was
17-fold low er than that obtained w ith
GlcA pLKrpSV2 LUC complexes in the presence74
of chloroquine and the transfection efficiency of
GlcA pLKrpSV2 LUC complexes in the presence74
of chloroquine was as great as that obtained with the
same amount of plasmid complexed with 5 mg lipo-
 .fectin data not shown .
3.4. Gene transfer into different cell lines
Plasmids encoding the firefly luciferase gene under
the control of either the SV40 large T antigen
 .pSV2 LUC or the human cytomegalovirus
 .pCMVLUC promoters were used to monitor the
transfection efficiency of various cell lines with
GlcA pLKrplasmid complexes in the presence of74
 .chloroquine Table 1 . Adherent cell lines including
 .those of a rabbit smooth muscle cells Rb-1 , rat
 .brain endothelial cells RBE4 , mouse melanoma cells
 .  .B16 , human osteosarcoma cells HOS or human
 .hepatoma cells HepG2 , were efficiently transfected.
 .Lewis Lung carcinoma cells 3LL and HeLa cells
were transfected with a relatively low efficiency.
Non-adherent cell lines including human ery-
 .throleukaemia cells HEL and K562 were also trans-
fected. On the opposite, some non-adherent cell lines
 .such as human myelocytic cells THP1 , human pro-
Table 1
Efficiency of gene transfer with GlcA pLKrplasmid complexes74
into various cell lines
Cells RLUrmg protein
pSV2 LUC pCMVLUC
GlcA pLK pLK GlcA pLK pLK74 74
‡ †HepG2 q 1540 10 4000 20
‡HOS q 100 1 820 10
§HEL y 20 1 790 10
§K562 y 210 nd nd nd
§THP1 y 1 1 1 1
‡HeLa q 50 0.5 nd nd
§HL60 y 1 nd nd nd
§Jurkat y 1 1 nd nd
‡3LL q 100 5 nd nd
‡B16 q 910 10 nd nd
‡Rb-1 q 390 5 nd nd
§RBE4 q 5 1 260 10
All transfections were performed with 5 mg plasmid complexed
with the minimal amount of polymer leading to a complete
retardation of the plasmid DNA in agarose gel electrophoresis,
i.e., either 6 mg GlcA pLK or 2.5 mg pLK per assay. † q,74
adherent cells; y, non-adherent cells; the luciferase activity was
measured § 24 h and ‡ 48 h after the transfection conducted for 4
h in the presence of 100 mM chloroquine. nd, not determined.
RLUrmg protein in non-transfected cells was 0.1.
 .myelocytic cells HL60 and human lymphoid cells
 .Jurkat were transfected with a very low efficiency.
The luciferase activity into each cell line transfected
with gluconoyl-free pLKrDNA complexes was al-
ways very low. The luciferase gene expression de-
pended both on the promoter used and on the cell
line: the luciferase activity in HEL and RBE4 cells
was rather low after transfection with pSV2 LUC but
quite high with pCMVLUC; HepG2 cells were trans-
fected with a very high activity in both cases.
3.5. Solubility of polymerrplasmid complexes
The solubility of complexes containing pSV2 LUC
and either GlcApLK, pLK, LactpLK or Lact-,
GlcApLK was compared by dispersing them in PBS
and estimating the turbidity by measuring the ab-
 .sorbance at 610 nm Fig. 4 . pLK and GlcA pLK74
formed highly soluble complexes with pSV2 LUC
 .from 5 mgrml up to 100 mgrml 30 nM DNA. On
the opposite, the solubility of the plasmid complexed
with LactpLK was low and depended on the number
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Fig. 4. Concentration-dependent solubility of the polymerrplas-
mid complexes. Complexes were formed by mixing pSV2 LUC
 .1.5–30 pmol; 5–100 mgrml with the minimal amount of
polymer leading to a complete retardation of all the plasmid in
 . agarose gel electrophoresis, i.e., either v pLK polymerrDNA
.  . molar ratio s28 , ‘ GlcA -pLK polymerrDNA molar ratio74
.  .  .  .s74 , \ Lact -pLK polymerrDNA molar ratio s52 , I30
 .  .Lact -pLK polymerrDNA molar ratio s114 or % Lact ,60 30
 .
-GlcA -pLK polymerrDNA molar ratio s78 in 1 ml of PBS.50
The solutions were kept for 30 min at 208C and then their
turbidity assessed by measuring the absorbance at 610 nm.
of Lact molecules bound per pLK molecule: the
absorbance of the solutions containing a plasmid
complexed with lactosylated polylysines Lact pLK60
.and Lact pLK increased drastically above 1030
mgrml and 30 mgrml, respectively. In contrast, the
addition of 50 GlcA on a slightly lactosylated polyly-
 .sine Lact -, GlcA pLK increased drastically the30 50
solubility of the DNA complex which became as
soluble as that formed with GlcA pLK or with pLK.74
3.6. Gene transfer with plasmid complexed with a
lactosylated and gluconoylated polylysine
HepG2 cells bind and internalize glycoproteins
containing b-D-galactosyl residues in a non-reducing
terminal position due to the presence of a galactose-
w xspecific membrane lectin 23 . We previously showed
that HepG2 cells were easily transfected by Lact-
pLKrplasmid complexes in a sugar-dependent man-
w xner 10 when the polypeptide was substituted with
59"4 Lact residues when 31"4% of the e-amino
. w xgroups of the pLK was substituted 7 . The luciferase
activity was high when pLK contained 60 Lact,
whereas it was 40-fold lower when pLK contained 30
 .Lact Fig. 5 . In order to decrease both the number of
Lact and the number of positive charges of the
lactosylated polylysine, pLK substituted with 30 Lact
molecules was partially gluconoylated. The luciferase
activity into HepG2 cells transfected with the Lact -,30
GlcA pLKrpSV2 LUC complex was 40-fold higher50
than that obtained with the Lact pLKrpSV2 LUC30
complex and was as great as that obtained with the
 .Lact pLKrpSV2 LUC complex Fig. 5 . A lower60
substitution of Lact pLK with GlcA residues did not30
enhance the transfection efficiency: the luciferase
activity after a transfection with the Lact -,30
GlcA pLKrpSV2 LUC complex was as low as that30
obtained with the Lact pLKrpSV2 LUC complex30
 .Fig. 5 . Similarly, a higher substitution of Lact pLK30
with GlcA residues decreased the transfection effi-
ciency: after transfection with the Lact -,30
GlcA pLKrpSV2 LUC complex, it was 25-fold less80
than with the Lact -, GlcA pLKrpSV2 LUC com-30 50
 .plex Fig. 5 .
3.7. Charge ratio in polymerrplasmid complexes
Cationic compounds interact strongly and non-
specifically with the cell surface and in addition
w xactivate the complement system 24 . The global
Fig. 5. Gene transfer with lactosylated and gluconoylated polyly-
sinerplasmid complexes. HepG2 cells were transfected at 378C
for 4 h in 1 ml of DMEM containing 1% FBS, 100 mM
 .chloroquine and pSV2 LUC 1.5 pmol complexed with the mini-
mal amount of polymer leading to a complete retardation of all
the plasmid in agarose gel electrophoresis, i.e., either pLK 2.5
.  .mg; 43 pmol , Lact pLK 5 mg; 78 pmol , Lact -, GlcA pLK30 30 30
 .  .6 mg; 98 pmol , Lact -, GlcA pLK 7.5 mg; 117 pmol ,30 50
 . Lact -, GlcA pLK 10 mg; 156 pmol , Lact pLK 12.5 mg;30 80 60
.  .170 pmol or GlcA pLK 6 mg; 108 pmol . Gene expression74
was determined 48 h later by assaying the luciferase activity in
cell lysates. Lact and GlcA were the number of lactosyl and
gluconoyl residues per polylysine molecule, respectively.
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charge of polymerrplasmid complexes was calcu-
lated from the ratio between the average number of
 .positive charges free e-amino groups of polymer
per negative charges phosphate groups of a nu-
.cleotide residue in complexes made with the lowest
polymer to DNA molar ratio leading to the complete
 .retardation of all the DNA in electrophoresis Fig. 6 .
For this calculation, it was assumed that 100% of the
free e-amino groups were protonated and that 100%
of the phosphodiester groups were charged.
GlcApLKrpSV2 LUC complexes had an excess of
negative charges that weakly depended on the num-
ber of gluconoyl residues bound per pLK molecule:
the NHqrnucleotide ratio was 0.54 with pLK and 0.83
with GlcA pLK. In contrast, LactpLKrpSV2 LUC74
complexes had an excess of positive charges that
increased when the number of lactosyl residues bound
per pLK molecule increased: the NHqrnucleotide3
ratio was 0.75, 1.6 and 2.8 with Lact pLK,30
Lact pLK and Lact pLK, respectively. The addi-60 80
tion of 50 GlcA residues on a slightly lactosylated
 .polylysine Lact -, GlcA pLK allowed the forma-30 50
tion of lactosylated polymerrDNA complexes con-
taining an average number of positive charges close
to that of negative charges.
Fig. 6. Charge ratio in polymerrplasmid complexes. Influence of
the polylysine substitution level on the NHqrnucleotide ratio in3
 . complexes between pSV2 LUC and either ‘ GlcA pLK 0- xx
.  .  .  .-105 , I Lact pLK 0- x -76 or % Lact GlcA pLKx 30 x
 . q0- x -80 . The NH rnucleotide ratio is the ratio of the3
average number of free e-amino groups assuming that 100% of
. them are protonated and of phosphate groups assuming that
.100% of them are charged in polymerrDNA complexes made
with the lowest polymer to DNA molar ratio leading to the
complete retardation of all the DNA in electrophoresis.
4. Discussion
The transfection efficiency of mammalian cells
with polylysinerplasmid DNA complexes which is
generally low, became more efficient when about
one-third of the e-amino groups of the polypeptide
was blocked by acylation with d-gluconolactone.
 .Polylysines DP 190 partially substituted with glu-
conoyl residues form complexes with plasmids in
which the electrostatic interactions are reduced. In
solution, the dissociation of the plasmid from pLK
substituted with 74 or 110 GlcA molecules was easier
than the dissociation of the plasmid from pLK, i.e.,
 .required a lower ionic strength Fig. 2 . The
GlcApLKrDNA complexes were highly efficient in
transfecting HepG2 cells when pLK was substituted
with 81"7 GlcA residues when 43"4% of the
.  .e-amino groups were substituted Fig. 3A ; the trans-
fection efficiently reached a plateau when
GlcApLKrplasmid complexes were formed with the
lowest polymer to plasmid molar ratio giving a com-
plete retardation of all the DNA in electrophoresis
 .  .Fig. 3B . Under these conditions 1 GlcApLK was
totally associated with the plasmid and no further
purification was required to remove free GlcApLK
since the concentration of GlcApLK remaining free
 .was negligible; 2 GlcApLKrDNA complexes were
 .  .anionic Fig. 6 and 3 the luciferase activity was as
great as that obtained with cationic complexes con-
 .taining an excess of GlcApLK Fig. 3B . Because
GlcApLKrDNA complexes enter the cells through
an endocytic pathway, transfections must be per-
formed in the presence of either chloroquine or a
fusogenic peptide to help the DNA to cross intra-
cellular membranes and to reach the cytosol. Chloro-
quine prevents the delivery of the endosomal content
w xto lysosomes 25 , induces the formation of large
w xvacuoles 26 and in addition allows the dissociation
of polylysinerplasmid complexes as shown previ-
w xously 27 . A fusogenic peptide, able to disrupt the
membrane of acid vesicles, is known to help the
w xDNA to reach the cytosol 10,28,29 . When com-
pared to other transfection methods, transfection of
HepG2 cells with the same amount of plasmid com-
plexed with DEAE-dextran was very low; transfec-
tion with lipofectin reagent was as efficient as with
GlcA pLKrplasmid complex in the presence of74
chloroquine.
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We showed that a Lact pLKrpSV2 LUC com-30
plex, which was much less efficient than a
Lact pLKrpSV2 LUC complex in transfecting60
w xHepG2 cells 7 , became highly efficient after addi-
tion of 50 GlcA residues in order to reduce the
number of remaining positive charges on the polyca-
 .tion Fig. 5 . Therefore, partially gluconoylated
polylysine containing reduced number of positive
charges can serve as a polycation to link a small
number of molecules acting as recognition signals
such as carbohydrates in order to target gene into
cells expressing specific membrane lectins. The ad-
vantages of using a partially gluconoylated polylysine
bearing a small number of sugar residues over
polylysine bearing a great number of sugar residues,
are that gluconoylated and glycosylated
 .polylysinerplasmid complexes 1 are highly soluble
 .  .above 100 mgrml in DNA Fig. 4 which is of
 .great interest for in vivo applications; 2 are not
 .  . cationic Fig. 6 and 3 form small particles 25–50
.nm in diameter , the size of which are close to those
obtained with sugar-free gluconoylated polylysine
 .Delain et al., in preparation . In addition, the reduc-
tion of the number of sugar residues required on
gluconoylated polylysine for efficient and specific
delivery will be much less expensive, especially when
complex oligosaccharides are used.
Partially gluconoylated polylysine and those bear-
ing a small number of sugar moieties acting as
recognition signals are synthetic compounds, rapidly
prepared and easily purified; it was shown that glu-
conoylated and glycosylated polylysine is not im-
w x w xmunogenic 1 and is totally biodegradable 8 . Re-
cently, synthetic cationic molecules, including
polylysine, involved in non-viral gene delivery sys-
tems and their complexes with DNA were shown to
induce a strong activation of the complement system
which decreased when the charge ratio of complexes
w xdecreased 24 . Therefore, DNA complexes made
with gluconoylated polylysine and gluconoylated
polylysine bearing a small number of sugar moieties
 .which are not cationic Fig. 6 should be inefficient
in activating the complement.
GlcA pLKrplasmid complexes were suitable to74
transfect different cell lines including adherent and
 .non-adherent cells Table 1 . The transfection effi-
ciency depends on the cell lines and is also related to
 .1 the nature of the promoter which controls the
 .gene expression; 2 the efficiency of the uptake of
the complexes by a receptor-independent endocytosis
– the gluconoyl molecule is not known to be recog-
 .nized by cell surface receptors; 3 the intracellular
 .traffic of the complexes after internalization and 4
the efficiency of the transmembrane passage of the
plasmid into the cytosol in relation to the intracellular
concentration of chloroquine or to the membrane-dis-
rupting efficiency of a fusogenic peptide. In conclu-
sion, partially gluconoylated polylysine, and those
bearing a small number of sugar moieties acting as
recognition signals specific for membrane lectins, are
good non-viral vehicles for gene transfer into several
eukaryotic cells in a receptor-independent and in a
receptor-dependent manner, respectively.
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